公司資料
LENSAR 股價、新聞與催化劑
- 股票代碼:
- LNSR
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
8.44 USD (-3.21%)
收盤價
最後更新: 2026年8月20日
69.5M USD
市值
股價為何變動
As of Aug 20, 2026, LNSR closed down 3.21% at $8.44. No new same-company headline was identified in the current news window.
公司概覽
Robotic Cataract Technology
LENSAR develops advanced laser systems for cataract surgery. Its technology is intended to automate key surgical steps and help ophthalmic surgeons plan and execute precise, astigmatism-aware procedures.
ALLY System
The ALLY Robotic Cataract Laser System combines imaging, planning and femtosecond-laser capabilities in a compact platform designed for use in the operating room. LENSAR places systems with ophthalmic practices and surgery centers, then generates recurring revenue from procedure-linked consumables, service and upgrades.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。